precision cancer medicine | sciencenewsnet.in

Breaking News

Roy Choi Will Speak to Cal State Fullerton’s Class of 2024

Compact quantum light processing

Researchers develop a new way to safely boost immune cells to fight cancer

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

RCT finds calories may be more important than meal timing when it comes to weight loss

Newer antibiotics underprescribed for highly resistant infections

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

20 Apr, 2024

AACR 2023: Ohio State experts share new findings on immuno-oncology, ‘smart-drugs,’ obesity-related endometrial cancers and other research topics

April 12, 2023 sarah JonasResearch Tip Sheet

New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

August 12, 2022 sarah JonasResearch Results

The targeted therapy pralsetinib was well-tolerated and demonstrated high response rates in patients with RET gene fusions regardless of tumor type, according to results from the Phase I/II ARROW trial.